Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 13/20 | 0.80 |
| ▸ | OPRM1 | P35372 | 9/20 | 0.80 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.80 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dadle SCHEMBL11396067 | 1.00 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| Dadle SCHEMBL11124725 | 1.00 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| Dadle SCHEMBL28363457 | 1.00 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| Dadle SCHEMBL11683986 | 1.00 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| Dadle SCHEMBL11396064 | 1.00 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| SCHEMBL8077734 | 0.94 | OPRD1 (0.73) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29355873 | 0.94 | OPRD1 (0.73) | OPRD1OPRM1OPRK1 | |
| SCHEMBL8077732 | 0.94 | OPRD1 (0.73) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29925300 | 0.94 | OPRD1 (0.74) | OPRD1OPRM1OPRK1 | |
| SCHEMBL11683004 | 0.94 | OPRD1 (0.69) | OPRD1OPRM1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160271248-A1 | CXCR4 UP- AND DOWN-REGULATION FOR TREATMENT OF DISEASES OR DISORDERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-09-22 | — | — | US | disclosed |
| WO-2015051279-A2 | CXCR4 UP- AND DOWN-REGULATION FOR TREATMENT OF DISEASES OR DISORDERS | DREXEL UNIVERSITY (US) | 2015-04-09 | — | — | WO | disclosed |